Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclosporine and Metformin in Psoriasis
NCT07375654Phase 1Completed
- Sponsor
- Cairo University
- Start
- Dec 2024
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of liquid metformin (Aspargo Labs) in psoriasis (2 arms), sponsored by Cairo University. Primary endpoints: Psoriasis Area and Severity Index at 24 weeks, Body Surface Area at 24 weeks and 1 more. Started Dec 2024; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
psoriasis
Beyond the preview
Go deeper on NCT07375654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07375654.